Welcome to LookChem.com Sign In|Join Free
  • or
HENAN SUNLAKE ENTERPRISE CORPORATIONAniracetam//file1.lookchem.com/cas/reactions/2021/06/01/4807205.png
qq

Communicate with Supplier:

Ms. summer
Ms. summer: What can I do for you?

Aniracetam CAS NO.72432-10-1

Min.Order Quantity:
1 Kilogram
Purity:
98%
Port:
TIANJIN/SHANGHAI
Payment Terms:
L/C,D/P,T/T,

Add to Inquiry Cart

Product Details

Keywords

  • 1-p-anisoyl-2-pyrrolidinone
  • 1-(4-methoxybenzoyl)-2-pyrrolidinon
  • draganon

Quick Details

  • ProName: Aniracetam
  • CasNo: 72432-10-1
  • Molecular Formula: C12H13NO3
  • Appearance: Crystalline Solid
  • Application: 18342-39-7
  • DeliveryTime: within 7-10days after receiving paymen...
  • PackAge: as required
  • Port: TIANJIN/SHANGHAI
  • ProductionCapacity: 200 Kilogram/Month
  • Purity: 98%
  • Storage: Room temperature
  • Transportation: by sea/ by express
  • LimitNum: 1 Kilogram

Superiority

aniracetam basic information
levetiracetam class brain cell metabolism drugs pharmacological effects pharmacokinetics adverse reactionsprecautions chemical properties application production methods
product name: aniracetam
synonyms: 1-(4-methoxybenzoyl)-2-pyrrolidinon;1-(p-methoxybenzoyl)-2-pyrrolidinon;1-p-anisoyl-2-pyrrolidinone;draganon;sarpul;1-(4-methoxybenzoyl)-2-pyrrolidinone;aniracetam;ro 13-5057
cas: 72432-10-1
mf: c12h13no3
mw: 219.24
einecs:
product categories: glutamate;aromatics;heterocycles;intermediates & fine chemicals;pharmaceuticals;smart drug;nootropic
mol file: 72432-10-1.mol
aniracetam structure
aniracetam chemical properties
mp 121-122 c
storage temp. store at rt
cas database reference 72432-10-1(cas database reference)
safety information
wgk germany 2
rtecs uy5781900
msds information
provider language
1-(4-methoxybenzoyl)-2-pyrrolidinone english
sigmaaldrich english
aniracetam usage and synthesis
levetiracetam class brain cell metabolism drugs aniracetam, also known as aniracetam, together with piracetam and nefiracetam, belong to the same class of piracetam metabolized drugs of brain cells. these drugs can enhance the activity of synaptic neurons phospholipase, increase the atp formation and transport in brain, increase protein synthesis and rna, promote the usage of brain on amino acids, phospholipids, glucose and oxygen, increase the patient's response, excitability and memory. aniracetam has a higher effect than piracetam, but with a relatively minor side effect.
pharmacological effects aniracetam, a cyclized derivative of γ- aminobutyric acid, can improve the brain function. it can selectively exert effect on central nervous system through penetration into blood-brain barrier. it can activate the metabolism activity of brain cell and protect the nerve cells. this product can also promote the intelligence by affecting the glutamate receptor system. moreover, it improves skin’s resistance to hypoxia, preventing the occurrence of malfunction of learning and memory caused by a variety of chemical substances, hypercapnia, scopolamine and electrical shock. this product has no sedative or excitation effect. animal experiments show that this product promotes the memory recovery in normal rats’ learning process. it can fight against hypoxia-induced memory recession and relieve the memory malfunction caused by certain reasons.
[indications] it is used for the treatment of mild or moderate malfunction of learning, memory and cognition in vascular dementia and alzheimer's disease. it can also be used for treating memory recession after stroke, memory defect in old people and children who undergo development retardation.
the above information is edited by the chemicalbook of dai xiongfeng.
pharmacokinetics according to literature, it is rapidly absorbed after oral administration by rats. the plasma concentration reaches highest level within 20 to 40 minutes. the drug is mainly distributed in the gastrointestinal tract, kidney, liver, brain and blood. after 24 hours, 77% to 85% is excreted out through urine, 4% from faeces. major metabolite in urine is n-p-anisoyl-aminobutyric acid and 5-hydroxy-2-pyrrolidone.
human: after oral administration, half-life of blood plains drug elimination averages at 20 to 30 minutes. plasma concentration becomes undetectable after two hours.
adverse reactions this product has fewer adverse reactions, occasionally dry mouth, anorexia, constipation, dizziness, and drowsiness. they disappear after stopping taking the drug.
precautions 1. adjust the dose for patients of liver dysfunction.
2. it can deteriorate the symptoms of huntington's chorea.
3. patients who is allergic to this drug or other pyrrolidone-class drugs are not allowed.
4. safety range: 0.3 ~ 1.8g / d.
chemical properties crystallization from ethanol, m.p. 12l ~ 122 °c. acute toxicity ld50 for rat, mouse (mg / kg): 4500,> 5000 oral.
application 1. piracetam derivative, a improvement agent for γ-lactam brain function. selectively exert effect on the brain system, promote and enhance memory function. compared with piracetam, it has a stronger effect, faster onset of action, and lower toxicity. used for improving brain function, especially treating the behavioral and mental disorders for sequela patients of senile dementia, cerebrovascular disease.
2. it is a γ-lactam-class agent of improving brain function. it can exert on the brain tissue through penetrating the blood-brain barrier, and improve brain function and memory.
production methods method 1: reflux the reaction mixture of 2- pyrrolidone and methoxy benzoyl chloride at 0~10 °c in ether and in the presence of triethylamine for three hours to get the aniracetam.
method 2: perform the reaction between p-methoxy benzoic acid and thionyl chloride to get the methoxy benzoyl chloride (yield 90%). then perform the reaction between methoxybenzoyl chloride and 4-aminobutyric acid in an aqueous solution of sodium hydroxide and in the presence of benzyl triethyl ammonium salt (of teba) to get 4- (4-methoxybenzoyl) amino butyric acid (yield 69.4%). then have cyclization reaction in the presence of toluene and thionyl chloride to get aniracetam, yield 80.4%, mp 118 ~ 120 °c.
method 3: methoxybenzoic acid is chloridized as post-methoxy benzoyl chloride first. then it is reacted together with sodium 2-pyrrolidone in tetrahydrofuran and 4-dimethylaminopyridine (dmap) to obtain the aniracetam yield 76.2% (take account of p-methoxy benzoyl chloride), the melting point of 118 ~ 119 °c.
method 4: 2-pyrrolidone was refluxed 1 hour in toluene containing sodium methoxide first. then methanol was totally evaporated. add teba at 10 °c, titrate a toluene solution of p-anisoyl chloride and stir them at room temperature for 0.5h. then stirred at 50 °c for 6h to obtain the aniracetam of 85% yield (take account of 2-pyrrolidone), melting point 120 ~ 121 °c.
method 5: 2-pyrrolidinone and triethylamine is mixed at 0 ~ 10 °c first. then perform titration of chlorotrimethylsilane for 2 h reaction at room temperature. add the dioxane solution of methoxybenzoyl chloride and stir 2h at 40 °c to obtain aniracetam, yield 65%.
chemical properties crystalline solid
usage cognitive enhancer
usage cognition enhancer related to piracetam. nootropic.
biological activity nootropic, with modulatory actions through allosteric potentiation of ampa specific receptors, reduction of glutamate receptor desensitization and potentiation of metabotropic glutamate receptor activity. anxiolytic following systemic administration.
henan sunlake enterprise corporation

our advantages

1, any inquiry about chemicals will be welome and replied within 24 hours;

2, competitive price;

3, good quality is guaranteed;

4, fast and safe delivery;

5, full experience in manufacture and international trade;

6, perfect and professional service.

Details

product information

aniracetam basic information
levetiracetam class brain cell metabolism drugs pharmacological effects pharmacokinetics adverse reactionsprecautions chemical properties application production methods
product name: aniracetam
synonyms: 1-(4-methoxybenzoyl)-2-pyrrolidinon;1-(p-methoxybenzoyl)-2-pyrrolidinon;1-p-anisoyl-2-pyrrolidinone;draganon;sarpul;1-(4-methoxybenzoyl)-2-pyrrolidinone;aniracetam;ro 13-5057
cas: 72432-10-1
mf: c12h13no3
mw: 219.24
einecs:
product categories: glutamate;aromatics;heterocycles;intermediates & fine chemicals;pharmaceuticals;smart drug;nootropic
mol file: 72432-10-1.mol
aniracetam structure
aniracetam chemical properties
mp 121-122 c
storage temp. store at rt
cas database reference 72432-10-1(cas database reference)
safety information
wgk germany 2
rtecs uy5781900
msds information
provider language
1-(4-methoxybenzoyl)-2-pyrrolidinone english
sigmaaldrich english
aniracetam usage and synthesis
levetiracetam class brain cell metabolism drugs aniracetam, also known as aniracetam, together with piracetam and nefiracetam, belong to the same class of piracetam metabolized drugs of brain cells. these drugs can enhance the activity of synaptic neurons phospholipase, increase the atp formation and transport in brain, increase protein synthesis and rna, promote the usage of brain on amino acids, phospholipids, glucose and oxygen, increase the patient's response, excitability and memory. aniracetam has a higher effect than piracetam, but with a relatively minor side effect.
pharmacological effects aniracetam, a cyclized derivative of γ- aminobutyric acid, can improve the brain function. it can selectively exert effect on central nervous system through penetration into blood-brain barrier. it can activate the metabolism activity of brain cell and protect the nerve cells. this product can also promote the intelligence by affecting the glutamate receptor system. moreover, it improves skin’s resistance to hypoxia, preventing the occurrence of malfunction of learning and memory caused by a variety of chemical substances, hypercapnia, scopolamine and electrical shock. this product has no sedative or excitation effect. animal experiments show that this product promotes the memory recovery in normal rats’ learning process. it can fight against hypoxia-induced memory recession and relieve the memory malfunction caused by certain reasons.
[indications] it is used for the treatment of mild or moderate malfunction of learning, memory and cognition in vascular dementia and alzheimer's disease. it can also be used for treating memory recession after stroke, memory defect in old people and children who undergo development retardation.
the above information is edited by the chemicalbook of dai xiongfeng.
pharmacokinetics according to literature, it is rapidly absorbed after oral administration by rats. the plasma concentration reaches highest level within 20 to 40 minutes. the drug is mainly distributed in the gastrointestinal tract, kidney, liver, brain and blood. after 24 hours, 77% to 85% is excreted out through urine, 4% from faeces. major metabolite in urine is n-p-anisoyl-aminobutyric acid and 5-hydroxy-2-pyrrolidone.
human: after oral administration, half-life of blood plains drug elimination averages at 20 to 30 minutes. plasma concentration becomes undetectable after two hours.
adverse reactions this product has fewer adverse reactions, occasionally dry mouth, anorexia, constipation, dizziness, and drowsiness. they disappear after stopping taking the drug.
precautions 1. adjust the dose for patients of liver dysfunction.
2. it can deteriorate the symptoms of huntington's chorea.
3. patients who is allergic to this drug or other pyrrolidone-class drugs are not allowed.
4. safety range: 0.3 ~ 1.8g / d.
chemical properties crystallization from ethanol, m.p. 12l ~ 122 °c. acute toxicity ld50 for rat, mouse (mg / kg): 4500,> 5000 oral.
application 1. piracetam derivative, a improvement agent for γ-lactam brain function. selectively exert effect on the brain system, promote and enhance memory function. compared with piracetam, it has a stronger effect, faster onset of action, and lower toxicity. used for improving brain function, especially treating the behavioral and mental disorders for sequela patients of senile dementia, cerebrovascular disease.
2. it is a γ-lactam-class agent of improving brain function. it can exert on the brain tissue through penetrating the blood-brain barrier, and improve brain function and memory.
production methods method 1: reflux the reaction mixture of 2- pyrrolidone and methoxy benzoyl chloride at 0~10 °c in ether and in the presence of triethylamine for three hours to get the aniracetam.
method 2: perform the reaction between p-methoxy benzoic acid and thionyl chloride to get the methoxy benzoyl chloride (yield 90%). then perform the reaction between methoxybenzoyl chloride and 4-aminobutyric acid in an aqueous solution of sodium hydroxide and in the presence of benzyl triethyl ammonium salt (of teba) to get 4- (4-methoxybenzoyl) amino butyric acid (yield 69.4%). then have cyclization reaction in the presence of toluene and thionyl chloride to get aniracetam, yield 80.4%, mp 118 ~ 120 °c.
method 3: methoxybenzoic acid is chloridized as post-methoxy benzoyl chloride first. then it is reacted together with sodium 2-pyrrolidone in tetrahydrofuran and 4-dimethylaminopyridine (dmap) to obtain the aniracetam yield 76.2% (take account of p-methoxy benzoyl chloride), the melting point of 118 ~ 119 °c.
method 4: 2-pyrrolidone was refluxed 1 hour in toluene containing sodium methoxide first. then methanol was totally evaporated. add teba at 10 °c, titrate a toluene solution of p-anisoyl chloride and stir them at room temperature for 0.5h. then stirred at 50 °c for 6h to obtain the aniracetam of 85% yield (take account of 2-pyrrolidone), melting point 120 ~ 121 °c.
method 5: 2-pyrrolidinone and triethylamine is mixed at 0 ~ 10 °c first. then perform titration of chlorotrimethylsilane for 2 h reaction at room temperature. add the dioxane solution of methoxybenzoyl chloride and stir 2h at 40 °c to obtain aniracetam, yield 65%.
chemical properties crystalline solid
usage cognitive enhancer
usage cognition enhancer related to piracetam. nootropic.
biological activity nootropic, with modulatory actions through allosteric potentiation of ampa specific receptors, reduction of glutamate receptor desensitization and potentiation of metabotropic glutamate receptor activity. anxiolytic following systemic administration.
company information

henan sunlake enterprise corporation is located in henan province , the central plain of china , which enjoys favorable geogeaphical position and convenient transportion, the com[any was established in june. 1998 , until now having more than 18 years experience in manufacturing & exporting chemical raw material .

sunlake is a professional manufacturer engaged in producing and selling chemicals,including organic & inorganic chemicals , pigments & dyestuffs , water treatment chemicals , food & feed additives and others . these products have been being well exported to europe , southeast asia , the middle east , africa , south america and some other countries and areas.

we sincerely welcome foreign friends to visit our plant for cooperation. with the idea of "quality first,credit priority, excellent service", we are highly acknowledged by customers for good quality and competitive price. more importantly , the company has a strong r & d team, who are professional engineers and scholars with ph. d. .so we are confident to serve you better with our high - quality products and professional team.

we are taking great efforts to provide our customers with demanded goods and professional services, and continuously improve our core ability of competition and get the momentum for sustainable development, and finally make us being a reliable and professional wupplier in international market.

we welcome any serious inquiries from all customers of the world, and sincerely hope to cooperate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)